Show simple item record

dc.contributor.authorMaddocks, M.
dc.contributor.authorBrighton, L.J.
dc.contributor.authorAlison, J.A.
dc.contributor.authorter Beek, L.
dc.contributor.authorBhatt, S.P.
dc.contributor.authorBrummel, N.E.
dc.contributor.authorBurtin, C.
dc.contributor.authorCesari, M.
dc.contributor.authorEvans, R.A.
dc.contributor.authorFerrante, L.E.
dc.contributor.authorFlores-Flores, O.
dc.contributor.authorFranssen, F.M.E.
dc.contributor.authorGarvey, C.
dc.contributor.authorHarrison, S.L.
dc.contributor.authorIyer, A.S.
dc.contributor.authorLahouse, L.
dc.contributor.authorLareau, S.
dc.contributor.authorLee, A.L.
dc.contributor.authorMan, W.D.-C.
dc.contributor.authorMarengoni, A.
dc.contributor.authorMcAuley, H.J.C.
dc.contributor.authorRozenberg, D.
dc.contributor.authorSinger, J.P.
dc.contributor.authorSpruit, M.A.
dc.contributor.authorOsadnik, C.R.
dc.date.accessioned2025-10-31T18:33:12Z
dc.date.available2025-10-31T18:33:12Z
dc.date.issued2023
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4886
dc.description.abstractPeople with respiratory disease have increased risk of developing frailty, which is associated with worse health outcomes. There is growing evidence of the role of rehabilitation in managing frailty in people with respiratory disease. However, several challenges remain regarding optimal methods of identifying frailty and delivering rehabilitation for this population. The aims of this American Thoracic Society workshop were to outline key definitions and concepts around rehabilitation for people with respiratory disease and frailty, synthesize available evidence, and explore how programs may be adapted to align to the needs and experiences of this population. Across two half-day virtual workshops, 20 professionals from diverse disciplines, professions, and countries discussed key developments and identified opportunities for future research, with additional input via online correspondence. Participants highlighted a “frailty rehabilitation paradox” whereby pulmonary rehabilitation can effectively reduce frailty, but programs are challenging for some individuals with frailty to complete. Frailty should not limit access to rehabilitation; instead, the identification of frailty should prompt comprehensive assessment and tailored support, including onward referral for additional specialist input. Exercise prescriptions that explicitly consider symptom burden and comorbidities, integration of additional geriatric or palliative care expertise, and/or preemptive planning for disruptions to participation may support engagement and outcomes. To identify and measure frailty in people with respiratory disease, tools should be selected on the basis of sensitivity, specificity, responsiveness, and feasibility for their intended purpose. Research is required to expand understanding beyond the physical dimensions of frailty and to explore the merits and limitations of telerehabilitation or home-based pulmonary rehabilitation for people with chronic respiratory disease and frailty.en_US
dc.description.sponsorshipFunding text 1: This document was funded by the American Thoracic Society.; Funding text 2: support from the National Institute for Health and Care Research (NIHR) Applied Research Collaboration South London (NIHR ARC South London) at King’s College Hospital NHS Foundation Trust. L.J.B. received research support from NIHR, Economic and Social Research Council. J.A.A. received research support from National Health and Medical Research Council Australia, Medical Research Futures Fund. S.P.B. served on an advisory committee for Boehringer Ingelheim, GlaxoSmithKline, Sanofi/Regeneron, Sunovion; served as a consultant for Boehringer Ingelheim, Sanofi/Regeneron; served as a speaker for Boehringer Ingelheim, IntegrityCE; received research support from NIH, Nuvaira, Sanofi/Regeneron. N.E.B. received research support from NIH. R.A.E. served as a consultant for AstraZeneca, British Medical Journal; served as a speaker for Boehringer Ingelheim, Chiesi, GlaxoSmithKline. L.E.F. received research support from NIH/NIA. O.F.F. received research support from Fogarty International Center and NIMH/NIH. F.M.F. served on an advisory committee for Chiesi, Novartis; served as a consultant for GlaxoSmithKline, Merck Sharp and Dohme; served as a speaker for AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis; received research support from AstraZeneca. C.G. served as a speaker for Boehringer Ingelheim. S.L.H. received research support from NIHR. A.S.I. served as a consultant for AstraZeneca; served as a speaker for Ascension; received research support from NIH, National Institute on Aging. L.L. served as a consultant for AstraZeneca; served as a speaker for Chiesi, ISPA vzw; received research support from Funds for Scientific Research Flanders. A.L.L. received research support from NHMRC, Australian Physiotherapy Association and Physiotherapy Research Foundation. W.D.C.M. received research support from NIHR. D.R. received research support from Sandra Faire and Ivan Fecan Professorship in Rehabilitation Medicine. J.P.S. served on an advisory committee for Altavant, Mallinckrodt, Onspira; served as a consultant for 4C Medical received research support from NIH. M.A.S. served on an advisory committee for GlaxoSmithKline; served as a consultant for AstraZeneca, Boehringer Ingelheim; received research support from AstraZeneca, Boehringer Ingelheim, Chiesi, Netherlands Lung Foundation, Stichting Astma Bestrijding, Teva. C.R.O. served as a speaker for Novartis Australia; received research support from Australian Physiotherapy Association Physiotherapy Research Foundation, European Respiratory Society, GlaxoSmithKline, Rebecca L Cooper Medical Research Foundation, Royal Australian College of General Practitioners. J.A.A., L.T.B., C.B., M.C., S.L., A.M., H.J.C.M. reported no commercial or relevant non-commercial interests from ineligible companies.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherAmerican Thoracic Society
dc.relation.ispartofurn:issn:2329-6933
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectFrailty and Care in Intensive Care Unitsen_US
dc.subjectFrailty in Older Adultsen_US
dc.titleRehabilitation for People with Respiratory Disease and Frailty An Official American Thoracic Society Workshop Reporten_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1513/AnnalsATS.202302-129ST
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.00
dc.type.otherResearch article
dc.identifier.journalAnnals of the American Thoracic Society
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2